Onset Still's Disease

Saakshi Khattri, M.D., and Peter Barland, M.D

Lupus nephritis is the most dreaded complication of SLE, especially if you're African American, Hispanic, male or less than 24 years old. We look at emerging therapies. >

Dr. Khattri is Senior Fellow and Dr. Barland is Professor of Medicine (emeritus), Albert Einstein College of Medicine, Bronx, NY.

Up In Smoke >

A Reprieve for HRT? >

Endometrial Cancer >

What to do about pressure ulcers. >

February 05, 2012 | LOGIN | REGISTER | HELP |

Current Conference

Previous Conferences

Palindromic Rheumatism Immunoglobulin G4-related Sclerosing Syndrome Hemophagocytic Syndrome in Rheumatic Diseases A Critical Review of the Role of Vitamin D Deficiency in Autoimmune
Diseases Parvovirus and Hepatitis C Virus Arthropathies Diabetic Muscular Infarction Intravenous Immunoglobulin Therapy in Rheumatological Disorders Targeting B cells in Systemic Lupus Erythematosus In Trials: Prospective Treatments for Rheumatoid Arthritis Atherosclerosis in Systemic Lupus Erythematosus Sjogren's Syndrome Scleroderma New Therapies for Rheumatoid Arthritis Vasculitis of the Central Nervous System Catastrophic Antiphospholipid Syndrome See more...

Moderator's Bio Other Specialties Corrections Discuss

Onset Still's Disease

CME credit is no longer available for this conference.

Release Date: 10/01/2001
Termination Date: 09/23/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.